Journal: Pharmaceutical Biology
Article Title: Cephaeline promotes ferroptosis by targeting NRF2 to exert anti-lung cancer efficacy
doi: 10.1080/13880209.2024.2309891
Figure Lengend Snippet: Inhibitory effects of cephaeline on lung cancer cells are alleviated by an NRF2 agonist. (A) The CCK-8 was used to detect the reversal effect of TBHQ (10 μM) on cephaeline (100 nM) induced lung cancer cell death, n = 3, Mean ± SD, ** p < 0.01 vs. the control group. (B) Using DCFH-DA probe to detect ROS level in control group, cephaeline treatment group and cephaeline combined TBHQ group. Scale bars, 50 μm. (C) The lipid peroxidation was measured by C11 BODIPY 581/591 fluorescent ratio-probe in control group, cephaeline treatment group and cephaeline combined TBHQ group. Scale bars, 20 μm. (D and E) Effect of cephaeline on LDH release and the key antioxidant GSH was detected in control group, cephaeline treatment group and cephaeline combined TBHQ group, n = 3. Mean ± SD, ** p < 0.01 vs. the control group. (F and G) The ferroptosis-related proteins GPX4, SLC7A11 were detected by western blot in control group, cephaeline treatment group and cephaeline combined TBHQ group, repeated three times, Mean ± SD, * p < 0.05, ** p < 0.01 vs. the control group.
Article Snippet: Purified cephaeline (>98%) (cas: 483-17-0) was purchased from Chengdu Biopurify Phytochemicals Ltd. (Chengdu, China).
Techniques: CCK-8 Assay, Control, Western Blot